☀️     🌓

Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

More ulcers with increased coxib use

The Canadian Medical [Association] Journal (CMAJ) has recently published a paper reviewing changes in the rates of upper gastrointestinal haemorrhage following the introduction of COX-2 selective non-steroidal anti-inflammatories (NSAIDs).

The paper compares changes in rates of GI bleeds in British Columbia and Ontario in comparison to changes in the use of NSAIDs following the introduction of COX-2 in patients aged 66 and over. In British Columbia, NSAID use rose by 2.2% (25% in relative terms) following the launch of COX-2 NSAIDs. This increase made no statistical difference to the rate of GI bleeds seen.

In Ontario, NSAID use rose by 5.6% (51% in relative terms), this increase may have contributed to the increased rate of GI bleeds observed. The observed number of GI bleeds was 26% greater than expected which is approximately 2 admissions be 10,000 patients.

In interpreting this paper the authors states that although COX-2 NSAIDs are associated with a lower risk of upper GI bleeding than traditional NSAIDs they still increase the risk compared to no treatment. It is therefore possible that a more cautious use of all NSAIDs may have avoided the increased number of GI bleeds seen in Ontario.

This study has some limitations it was observational, however there is a close temporal association seen between the introduction of COX-2 NSAIDs and the increased rate of upper GI bleeds. Additionally, the appropriateness of the treatment for individual patients and any benefits gained are unknown. Despite this it does appear that a more cautious use of new drugs may have may protect against adverse drug effects.

Action: Clinicians should consider the risks and benefits of possible treatments before recommending a particular therapy. This process should account for potentially unknown risks when drugs are new to the market.

Share 'More ulcers with increased coxib use' by emailShare 'More ulcers with increased coxib use' on FacebookShare 'More ulcers with increased coxib use' on TwitterShare 'More ulcers with increased coxib use' on LinkedInShare 'More ulcers with increased coxib use' on reddit


No Comments to “More ulcers with increased coxib use”

Leave a Comment

Your email address will not be published. Required fields are marked *

Please be aware that you comment is subject to our Privacy Policy.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Prescribing Advice for GPs is powered by ClassicPress.
Connect to our RSS or Atom Feeds.